来自微生物群的L-SeMet增强CD8+T细胞效应器功能,促进抗瘤反应
Simiao Fan1, Yaxin Li1, Shaoyi Huang1
1Nanhu Laboratory, National Center of Biomedical Analysis, Beijing 100850, China.
International journal of molecular sciences
|March 27, 2025
概括
肠道微生物代谢物L-selenomethionine (L-SeMet) 通过增强CD8+T细胞功能来增强免疫疗法. 这种代谢物被发现可以抑制小鼠的结直肠瘤生长,提供了一个新的治疗途径.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 肠道微生物群的代谢物调节免疫疗法的疗效.
- 这些代谢物的全部范围及其机制需要进一步阐明.
研究的目的:
- 为了确定增强抗瘤免疫疗法的新型肠道微生物代谢物.
- 调查L-selenomethionine (L-SeMet) 增强抗瘤免疫反应的机制.
主要方法:
- 对肠道微生物代谢物的查.
- 在体外评估L-氨酸对CD8+T细胞功效器功能的影响.
- 在大肠直肠癌 (MC38瘤) 的小鼠模型中评估L-SeMet的疗效.
- 阐明涉及T细胞受体 (TCR) 信号传递和LCK酸化的分子机制.
主要成果:
- 鉴定出L-selenomethionine (L-SeMet) 是一种增强CD8+T细胞效应因子功能的代谢物.
- 在小鼠中,L-SeMet的胃内注射显著抑制了皮下MC38瘤生长.
- 通过促进LCK酸化,L-SeMet被证明可以增强T细胞受体 (TCR) 信号传递.
结论:
- 肠道微生物代谢物L-selenomethionine (L-SeMet) 增强了抗瘤免疫疗法.
- 通过强化CD8+T细胞功能,L-SeMet可以抑制结直肠瘤的生长.
- L-SeMet代表了结直肠癌治疗的潜在治疗策略.
相关概念视频
The Tumor Microenvironment
6.3K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.3K
T Cell Types and Functions
3.2K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Cytotoxic T Cells-mediated Immune Response
7.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K
Tumor Immunotherapy
2.6K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K


